Local News ADCETRIS® Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin Lymphoma Seagen | February 4, 2022 Seagen announced that the Phase III ECHELON-1 clinical trial demonstrated a statistically significant improvement in…dcorriganFebruary 4, 2022 Read More
Local News Liver Institute Northwest Participating in RESPONSE, a Global Phase III Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC) BioSpace | February 2, 2022 Liver Institute Northwest is enrolling participants into RESPONSE, a global phase 3 clinical research study…dcorriganFebruary 2, 2022 Read More
Local News Promising Young Scientists: Moez Dawood Brotman Baty Institute | January 31, 2022 Moez Dawood has numerous opportunities to explore saturation genome editing working alongside BBI’s Dr. Lea…dcorriganJanuary 31, 2022 Read More
Local News ‘Continuum of Expertise’ of International Researchers Examines Pediatric Epilepsy Brotman Baty Institute | January 31, 2022 About 470,000 children in the United States are diagnosed with epilepsy, or 6.3 out of…dcorriganJanuary 31, 2022 Read More
Local News ‘Mix-and-Match’ Booster Strategy Is Safe, Effective UW Medicine | January 31, 2022 In adults who had previously received a full regimen of a COVID-19 vaccine approved or…dcorriganJanuary 31, 2022 Read More
Local News Tackling the Unknowns of Long-Haul COVID-19 Fred Hutch | January 28, 2022 Researchers worldwide, including many at Fred Hutchinson Cancer Research Center and the University of Washington,…dcorriganJanuary 28, 2022 Read More
Local News Study Details Changes in Omicron’s Spike Protein UW Medicine | January 28, 2022 An international team of scientists has determined the precise structural changes in the spike protein…dcorriganJanuary 28, 2022 Read More
Local News Diverse Protein Assemblies by (Negative) Design Insitute for Protein Design | January 28, 2022 Today we report in Science the design of new protein assemblies made from modular parts. These complexes…dcorriganJanuary 28, 2022 Read More
Local News Athira Pharma Announces Initiation of Patient Dosing in SHAPE, a Phase II Clinical Trial of ATH-1017 for the Treatment of Parkinson’s Disease Dementia and Dementia with Lewy Bodies Athira Pharma | January 27, 2022 Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal…dcorriganJanuary 27, 2022 Read More
Local News Supplement Appears to Boost Muscle, Mitochondria Health UW Medicine | January 26, 2022 An oral supplement intended to stimulate a natural body process appears to promote muscle endurance…dcorriganJanuary 26, 2022 Read More